A woman went to the ER to deal with severe abdominal pain, nausea and vomiting. She thought it might be due to stress, but ...

Eli Lilly draws fresh market attention as healthcare rotation, GLP treatment access, and obesity care demand strengthen its ...

Eli Lilly draws attention as wider GLP access, earnings strength, valuation debate, and regulatory updates shape its healthcare market story.

Popular GLP-1 weight-loss drugs are becoming much more affordable for millions of older adults starting Wednesday, July 1, as Medicare begins to cover them — for now. The Medicare GLP-1 Bridge is a ...

Some Medicare patients will be able to access to GLP-1 medication for weight loss for the first time starting July 1, paying a $50 monthly copay through a new program designed to make the drugs more ...

Before Serena Williams picked up her racket at London’s Andy Murray Arena last week, two questions hung over her return to tennis. First: How would she do? She answered that, in her first competition ...

Uncontrollable vomiting. Seizures. Throwing up blood. These are some of the horrifying symptoms people have reported after overdosing on GLP-1 drugs. Though the drugs have been around since 2005 to ...

Fertility may not be a reason for men to avoid GLP-1 medications. In fact, they could see an improvement. After 24 weeks of treatment with GLP-1s, a class of medications that treats diabetes and is ...

The arrival of summer means beach season is calling for many, which may lead some to chase the perfect swimsuit physique. A 2025 Gallup poll showed that 52% of Americans want to lose weight but that ...

The story of GLP-1 drugs keeps getting bigger. First they transformed the treatment of diabetes. Then they upended the science - and culture - of weight loss. Now a growing body of research is raising ...

Carley is a writer, editor and social media professional. Before starting at Forbes Health, she wrote for Sleepopolis and interned at PBS and Nickelodeon. She's a certified sleep science coach and ...

June 3 (Reuters) - A growing body of evidence suggests that popular GLP-1 drugs, widely used for weight loss and diabetes, can provide protection against many types of cancer. More than two dozen ...